Affiliation:
1. Kazan State Medical University;
Children’s Republican Clinical Hospital
2. Kazan State Medical University
3. Children’s Republican Clinical Hospital
Abstract
Hemolytic-uremic syndrome includes a triad of symptoms: microangiopathic hemolytic anemia, thrombocytopenia, and acute kidney injury. Given the progressive course of hemolytic-uremic syndrome, up to the terminal stage of renal failure, it is necessary to search for early markers of renal tissue damage as prognostically significant factors in the development of nephrosclerosis, which is of particular importance in childhood to optimize the management of such patients. The analysis of the literature data demonstrates the actual role of serotonin and platelet-mediated effect of serotonin on fibroinflammatory processes in kidney vessels. Thus, changes in the serotonergic system in patients already at the onset of hemolytic-uremic syndrome are of great interest in order to develop new diagnostic approaches that allow optimizing early diagnosis and slowing down the progression of renal damage in this category of patients. These studies will expand knowledge about the role of the serotonergic system in the formation of chronic kidney disease in children with hemolytic-uremic syndrome.
Publisher
The National Academy of Pediatric Science and Innovation
Subject
Pediatrics, Perinatology and Child Health
Reference24 articles.
1. Yoshida Y., Kato H., Ikeda Y., Nangaku M. Pathogenesis of Atypical Hemolytic Uremic Syndrome. J Atheroscler Thromb 2019; 26(2): 99-110. DOI: 10.5551/jat.RV17026
2. Lee H., Kang E., Kang H.G., Kim Y.H., Kim J.S., Kim H.J. et al. Consensus regarding diagnosis and management of atypical hemolytic uremic syndrome. Korean J Intern Med. 2020;35(1):25-40. DOI: 10.3904/kjim.2019.388
3. Bulatov V.P., Makarova T.P., Samojlova N.V., Emirova H.M. Hemolytic-uremic syndrome in children. Kazan: Meditsina, 2016; 144. (in Russ.)
4. Eddahibi S., Adnot S. The serotonin pathway in pulmonary hypertension. Arch Mal Coeur Vaiss 2006; 99(6): 621-625
5. Dziegiel P., Suder E., Surowiak P., Jethon Z., RabczyĔski J., Januszewska L. et al. Role of exogenous melatonin in reducing the nephrotoxic effect of daunorubicin and doxorubicin in the rat. J Pineal Res 2002; 33(2): 95-100. DOI: 10.1034/j.1600-079x.2002.02902.x